Primary Peritoneal Carcinoma — Trials

Primary Peritoneal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

294 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 92
Recruiting: 35
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06867562	Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer	not yet recruiting	Phase 3	166	Jina Pharmaceuticals Inc.INDUSTRY	0	Mar 10, 2025	clinicaltrials
NCT04515602	Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)	not yet recruiting	Phase 3	410	Shanghai Gynecologic Oncology GroupOTHER_GOV	1	Aug 27, 2020	clinicaltrials